Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
98 EUR | -1.01% |
|
-.--% | +2.08% |
06-21 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
06-21 | Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says | RE |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
633B | ||||||
356B | - | - | - | - | ||
328B | ||||||
304B | ||||||
244B |